D36.1
Benign neoplasm of peripheral nerves and autonomic nervous system
Clinical Classification Guidelines
Excludes Type 1
- benign neoplasm of peripheral nerves of orbit (D31.6-)
- neurofibromatosis (Q85.0-)
Medical Intelligence & Overview
Benign neoplasms of the peripheral nerves and autonomic nervous system are non-cancerous growths that develop from nerve tissues outside the brain and spinal cord. These growths can involve any part of the peripheral nervous system, including the nerves that control sensation and movement, or the autonomic nervous system, which manages involuntary functions such as heart rate, digestion, and blood pressure. Although these tumors are benign, meaning they are not malignant or cancerous, they may still cause discomfort or functional impairments depending on their size and location. The ICD-10 code D36.1 specifically categorizes these benign nerve tumors, assisting healthcare providers in diagnosis, treatment planning, and record-keeping.
Causes & Symptoms
Clinical Causes: Genetic factors: Certain inherited genetic conditions may predispose individuals to develop nerve tumors. Unknown factors: In many cases, the precise cause of these benign growths remains unclear. Environmental influences: No well-established environmental causes have been conclusively linked to the development of these tumors.
Key Symptoms: Mass or lump: Noticeable swelling or lump in the affected area, which may be painless or tender. Pain or discomfort: Some nerve tumors can cause localized pain, tingling, or numbness. Nerve-related symptoms: Depending on their location, these tumors can lead to weakness, loss of sensation, or other neurological deficits. Muscle weakness: In some cases, tumors pressing on nerves may result in decreased muscle strength or coordination. Autonomic symptoms: When affecting the autonomic nervous system, symptoms may include abnormal blood pressure, abnormal heart rate, or digestive issues.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and imaging studies. Physicians may perform a physical examination to assess for lumps or neurological deficits. Imaging tests such as MRI (Magnetic Resonance Imaging) are often used to visualize the tumor's size, location, and relationship to surrounding tissues. In some cases, a biopsy may be performed to confirm the benign nature of the growth and to rule out other types of tumors. Electrophysiological studies can also assist in assessing nerve function if symptoms are neurological in origin.
Treatment Protocols: Management of these benign nerve tumors varies depending on their size, location, and symptoms. Common treatment approaches include: - Observation: Small, asymptomatic tumors may simply be monitored over time with regular imaging studies. - Surgical removal: When the tumor causes significant symptoms or complications, surgical excision is often performed to remove the mass while preserving nerve function. - Symptom management: Pain relief and supportive therapies may be employed to improve quality of life. - Rehabilitation: Post-surgical therapy, including physical or occupational therapy, can help restore function and strength. Good communication with healthcare providers is essential to determine the most appropriate treatment plan tailored to individual circumstances.
Clinical Advice & FAQs
Billing Guidance
Is D36.1 a billable ICD-10 code?
Yes, D36.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D36.1?
Clinical documentation must specify the nature of Benign neoplasm of peripheral nerves and autonomic nervous system and any associated comorbidities for accurate reporting.
Cite this Clinical Reference